APA (7th ed.) Citation

SJ, B., LA, A., JE, H., SN, X., I, D., CS, G., . . . BT, A. (2022). Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Neuropharmacology, 219, 109214. https://doi.org/10.1016/j.neuropharm.2022.109214

Chicago Style (17th ed.) Citation

SJ, Belouin, et al. "Policy Considerations That Support Equitable Access to Responsible, Accountable, Safe, and Ethical Uses of Psychedelic Medicines." Neuropharmacology 219 (2022): 109214. https://doi.org/10.1016/j.neuropharm.2022.109214.

MLA (9th ed.) Citation

SJ, Belouin, et al. "Policy Considerations That Support Equitable Access to Responsible, Accountable, Safe, and Ethical Uses of Psychedelic Medicines." Neuropharmacology, vol. 219, 2022, p. 109214, https://doi.org/10.1016/j.neuropharm.2022.109214.